Introduction to the consensus recommendations

Plastic and Reconstructive Surgery

Volumn 114, Issue 6 SUPPL., 2004, Pages

  Carruthers, Jean ^a   Fagien, Steven ^b   Matarasso, Seth L ^c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Univ of California Sch of Medicine ^*

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

CLINICAL PRACTICE; CONSENSUS; DERMATOLOGY; DRUG INDICATION; DRUG USE; EDITORIAL; ESTHETICS; HUMAN; PATIENT SATISFACTION; PLASTIC SURGERY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; TREATMENT INDICATION; WRINKLE; ADULT; ARTICLE; CONSENSUS DEVELOPMENT; COUNSELING; FACE; MIDDLE AGED; PATIENT SELECTION; SUBCUTANEOUS DRUG ADMINISTRATION; UNITED STATES;

ADULT; BOTULINUM TOXIN TYPE A; CONSENSUS DEVELOPMENT CONFERENCES; COUNSELING; ESTHETICS; FACE; HUMANS; INJECTIONS, SUBCUTANEOUS; MIDDLE AGED; PATIENT SELECTION; PRACTICE GUIDELINES; UNITED STATES;

EID: 7044272494     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PRS.0000146690.73307.EF     Document Type: Editorial

References (10)

1. Leffell, D. J. Foreword. In M. S. Kaminer, J. S. Dover, and K. A. Arndt (Eds.), Atlas of Cosmetic Surgery, 1st Ed. Philadelphia: Saunders, 2002. Pp. ix-x.
2. Carruthers, A., and Carruthers, J. The treatment of glabellar furrow with botulinum A exotoxin. J. Dermatol. Surg. Oncol. 16: 83, 1990.
3. Carruthers, J. D., and Carruthers, J. A. Treatment of glabellar frown lines with C. botulinum-A exotoxin. J. Dermatol. Surg. Oncol. 18: 17, 1992.
4. Klein, A. W. Complications, adverse reactions, and insights with the use of botulinum toxin. Dermatol. Surg. 29: 549, 2003.
5. Fagien, S. Botulinum toxin type A for facial aesthetic enhancement: Role in facial shaping. Plast. Reconstr. Surg. 112 (Suppl.): 6S, 2003.
6. American Society for Aesthetic Plastic Surgery Cosmetic Surgery National Data Bank, 2003 Statistics. Available at http://www.surgery.org/download/2003- stats.pdf. Accessed June 15, 2003.
7. Allergan data on file, Physician ATU 2004. Irvine, Calif.: Allergan, Inc.
8. Allergan. Botox Cosmetic (botulinum toxin type A) purified neurotoxin complex (Package Insert). Irvine, Calif.: Allergan, Inc.
9. Carruthers, A., and Carruthers, J. Long-term safety review of subjects treated with botulinum toxin type A for cosmetic use. In Proceedings of the 13th Congress of the European Academy of Dermatology & Venereology, Florence, Italy, November 17-21, 2004.
10. Sommer, B., Zschocke, I., Bergfeld, D., Sattler, G., and Augustin, M. Satisfaction of patients after treatment with botulinum toxin for dynamic facial lines. Dermatol. Surg. 29: 456, 2003.